A detailed history of Eventide Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Eventide Asset Management, LLC holds 4,128 shares of LLY stock, worth $3.28 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,128
Previous 1,182 249.24%
Holding current value
$3.28 Million
Previous $1.07 Million 241.78%
% of portfolio
0.06%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $2.27 Million - $2.83 Million
2,946 Added 249.24%
4,128 $3.66 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $223,259 - $279,984
308 Added 35.24%
1,182 $1.07 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $517,582 - $692,452
874 New
874 $679,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.